COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) RANCHO CORDOVA, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, [...]
Unum Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
13/08/2018
– IND for First Solid Tumor Program, ACTR T cells in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers Now Active; Expect to Initiate Phase I Trial by End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 ( [...]
electroCore, Inc. Announces Second Quarter Financial Results
13/08/2018
BASKING RIDGE, N.J., Aug. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three month and six [...]
Acer Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Medical Affairs and Quality NEWTON, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a [...]
Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights
13/08/2018
-- Presented Preliminary Data from Three Clinical Trials of 5F9 as a Monotherapy and Combination Agent -- -- Granted Fast Track Designation from the U.S. Food and Drug Administration for 5F9 in Diffuse Large B-Cell [...]
Achaogen to Present at the Wedbush PacGrow Healthcare Conference
13/08/2018
-- Company presentation scheduled for August 14, 2018 at 8:00 a.m. EDT -- SOUTH SAN FRANCISCO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing [...]
Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
LIVONIA, Mich., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
Avinger Announces Second Quarter 2018 Financial Results
13/08/2018
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended [...]
Tetra Bio-Pharma Announces Initiation of Coverage by Paradigm Capital
13/08/2018
ORLEANS, Ontario, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced that Paradigm Capital, an [...]
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
13/08/2018
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation [...]
Park Vista Health Center Named Great Place to Work
13/08/2018
FULLERTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Park Vista Health Center in Fullerton, California, has been certified as a top workplace by the independent research and consulting firm Great Place to Work ®. Great [...]
CMS Proposed Rule Aims at AMA-Designed Paperwork Burden, States the Association of American Physicians and Surgeons (AAPS)
13/08/2018
TUCSON, Ariz., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Centers for Medicare and Medicaid Services (CMS) has issued a Proposed Rule to “blend” payments for higher-level office visits, while decreasing the documentation [...]
Stoneridge Creek Retirement Community Named Great Place to Work
13/08/2018
PLEASANTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Stoneridge Creek continuing care retirement community in Pleasanton, California, has been certified as a top workplace by the independent research and consulting [...]
Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2018
13/08/2018
Veloxis Upgrades 2018 Outlook Based on Strong Performance Copenhagen, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Highlights Veloxis upgrades 2018 Outlook based on strong performance. Product revenue for first half of 2018 was [...]
Sanofi: Disclosure of trading in own shares
13/08/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
13/08/2018
Pièce jointe Reporting FR.pdf
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
13/08/2018
Villepinte (France), le 13 août 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur la [...]
Ossur Hf : Transactions in relation to share buyback program
13/08/2018
Announcement no. 50/2018 13 August 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax
13/08/2018
Adds two revenue-generating FDA-licensed vaccines that protect against cholera and typhoid fever, both with dual-market potential Broadens development pipeline with an adenovirus 4/7 vaccine funded by the DoD for [...]

Pages